For multidrug-resistant #tuberculosis, the optimal duration of bedaquiline treatment is unknown.

Our #TargetTrial emulation: Bedaquiline for more than 6 months doesn't increase the probability of success.

Cloning+censoring+#IPweighting

https://www.atsjournals.org/doi/10.1164/rccm.202211-2125OC